There's a particular failure mode in biopharma AI that doesn't announce itself. The model runs, the analysis completes, the report looks reasonable. And somewhere inside it, a drug was counted twice because it was acquired and recoded. A terminated trial was missed because the stop reason

A busy start to 2026 at DrugBank. From new ways to access our knowledgebase to sharper clinical trial navigation, here’s a look at our recent product and data releases that help biopharma teams turn data into conviction.

2025 was a big year at DrugBank. We’re looking back at some of the biggest product releases and data updates that helped researchers explore the pipeline earlier and connect the dots across discovery and development.

Biomedical research is becoming increasingly complex, but finding answers shouldn’t be. Discover how DrugBank’s new AI Assistant transforms natural-language questions into instant, citable insights—empowering your team to move from fragmented data to confident strategy in seconds.

When multiple medications are administered together, they can sometimes interact to produce undesirable effects. This is an essential factor to consider during the drug development process. Let’s examine how the industry addresses this challenge.

Pharmaceutical companies must invest significant effort into developing novel drugs and ensure strict compliance with regulatory requirements to maintain market approval. Let’s explore how this process unfolds.

Many diseases can be traced to genetic origins, making gene regulatory networks a target for therapeutic intervention. Let’s explore how the emerging class of epigenetic drugs is poised to shape medicine and gain widespread prominence soon.

Before reaching consumers, drugs undergo rigorous testing to evaluate their safety and toxicity. Let’s explore the processes behind pharmaceutical safety assessments and the future of advancing drug safety.

Let’s explore how our platform is driving advancements in precision medicine and equipping those shaping the future of healthcare with our tools and insights.

COVID-19 has brought mRNA technology into focus. Let's examine how this technology is utilized in modern medicine.

No more scattered data. No more wasted time. The new DrugBank is here. An AI-powered, real-time intelligence platform built to accelerate your breakthroughs. With intuitive no-code tools, and continuously updated insights, you can move faster, make smarter decisions, and stay ahead of the curve.

The rollout of antibiotics in the 20th century significantly reduced mortality rates. However, bacteria have increasingly developed resistance to these life-saving drugs. Let’s explore how the pharmaceutical industry is addressing this growing challenge.

In this blog post, we’ll explore how the drug discovery phase of the development pipeline can be accelerated for faster, more efficient breakthroughs.

Drug repurposing offers a compelling solution by identifying new therapeutic uses for existing drugs. Let's explore how this approach is influencing drug discovery.

Using microscopic modifications, scientists can make drug delivery more efficient and effective. Let’s explore how nanotechnology is used in medicine to improve drug delivery.

Many diseases stem from genetic mutations that disrupt our bodies' normal functions. Excitingly, technologies now exist to edit and repair our DNA. Let's explore the latest breakthroughs in gene therapy.

The pharmaceutical drug development pipeline requires a large amount of resources and creates waste that can be hazardous to our ecosystems and public health. Let’s look at the efforts and guidelines in place to reduce the detrimental impact of drug development on our environment.

Rare diseases affecting fewer than 200,000 people are designated orphan diseases. Let's examine the regulation and development of drugs that can help treat these patients.

Chronic diseases are often the result of defective molecular pathways. Targeted therapies aim to fix or dampen a specific path and treat the disease. Let's examine how these therapies work further.

With the widespread use of smartphones and technology, the pharmaceutical industry has created new ways to deliver medicine and personalized therapies called digital therapeutics.

Certain compounds found in food can alter how drugs are metabolized in the body, affecting their efficacy. Let’s examine which compounds have food-drug interactions and how companies are finding solutions for this.